Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Income (Loss) Before Income Taxes
QFR111385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
34,748.00
Year-over-Year Change
13.95%
Date Range
10/1/2000 - 4/1/2025
Summary
This trend tracks the pre-tax income of U.S. pharmaceutical and medicine corporations on a quarterly basis. It provides critical insights into the financial health and performance of a key sector in the American healthcare and manufacturing economy.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The metric represents the aggregate earnings of pharmaceutical companies before accounting for income taxes, offering economists a direct view of sector-level profitability and economic contribution. It helps analysts understand industry-wide financial dynamics, investment potential, and potential impacts on broader economic indicators.
Methodology
Data is collected through comprehensive quarterly financial surveys of U.S. corporations in the pharmaceutical and medicine manufacturing sectors, compiled and reported by the U.S. Federal Reserve.
Historical Context
This trend is used by policymakers, investors, and economic researchers to assess the pharmaceutical industry's economic performance, potential regulatory impacts, and broader healthcare sector trends.
Key Facts
- Provides quarterly pre-tax income data for U.S. pharmaceutical corporations
- Reflects financial performance before tax considerations
- Offers insights into pharmaceutical sector economic health
FAQs
Q: What does this economic trend measure?
A: It measures the pre-tax income of U.S. pharmaceutical and medicine corporations on a quarterly basis, indicating the sector's financial performance.
Q: Why is this trend important for investors?
A: It provides a direct snapshot of pharmaceutical industry profitability, helping investors assess potential investment opportunities and sector-wide financial health.
Q: How is this data collected?
A: The U.S. Federal Reserve conducts comprehensive quarterly financial surveys of pharmaceutical corporations to compile this data.
Q: How do policymakers use this information?
A: Policymakers analyze this trend to understand industry economic performance, potential regulatory impacts, and broader healthcare sector dynamics.
Q: How frequently is this data updated?
A: The data is updated quarterly, providing a current view of the pharmaceutical sector's financial performance throughout the year.
Related News
Gen Z In the U.S. Shifts From Spending To Saving Habits
How Gen Z's Shift from Spending to Saving is Impacting the US Economy Recent trends indicate a significant shift in the spending habits of Gen Z, w...
U.S. Treasury Yields Decline After Inflation Data Meet Expectations
US Treasury Yields Drop as Inflation Data Meets Expectations US Treasury yields have seen a noticeable decline recently, as the latest inflation da...
S&P 500 Rises With Optimistic U.S. Inflation Report
S&P 500 Soars: Positive U.S. Inflation Developments The S&P 500, a primary stock index that tracks the performance of 500 major U.S. companies, has...
U.S. Stock Market Rises Amid PCE Inflation Report Analysis
U.S. Stock Market Climbs Amidst Insights from PCE Inflation Report Investors in the U.S. stock market are focusing on the most recent PCE Inflation...
U.S. GDP Growth to Slow Due to Tariffs and Immigration Policies
How Tariffs and Immigration Policies Influence U.S. GDP Growth in 2025 The U.S. GDP is a fundamental gauge of the country's economic health. Recent...
U.S. Stock Market Futures Rise On Inflation and Tariff News
US Stock Market Futures Rise Amid Inflation Data and Tariff News US stock market futures are on the rise, driven by significant updates in inflatio...
Related Trends
Quarterly Financial Report: U.S. Corporations: Iron, Steel, and Ferroalloys: Total Liabilities and Stockholders' Equity
QFR328371USNO
Quarterly Financial Report: U.S. Corporations: Plastics and Rubber Products: Short-Term Debt, Original Maturity of 1 Year or Less: Loans from Banks
QFR301326USNO
Quarterly Financial Report: U.S. Corporations: All Manufacturing: Total Assets
QFR223MFGUSNO
Quarterly Financial Report: U.S. Corporations: Food: Depreciation, Depletion, and Amortization of Property, Plant, and Equipment
QFR102311USNO
Quarterly Financial Report: U.S. Corporations: Printing and Related Support Activities: Other Direct Credits (Charges) to Retained Earnings (Net)
QFRD122323USNO
Quarterly Financial Report: U.S. Corporations: All Other Retail Trade: Income (Loss) from Operations
QFR104OTRUSNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Income (Loss) Before Income Taxes [QFR111385USNO], retrieved from FRED.
Last Checked: 8/1/2025